Cargando…
Platelet Protease Activated Receptor 1 Is Involved in the Hemostatic Effect of 20(S)-Protopanaxadiol by Regulating Calcium Signaling
Panax notoginseng (Burk.) F.H. Chen has long been used to stop bleeding for hundreds of years in China. At present, only dencichine, notoginsenoside Ft1, and 20(S)-protopanaxadiol (PPD) showed hemostatic effect. However, the molecular mechanism of PPD on the platelet aggragetion needs to be further...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530267/ https://www.ncbi.nlm.nih.gov/pubmed/33041793 http://dx.doi.org/10.3389/fphar.2020.549150 |
_version_ | 1783589536419282944 |
---|---|
author | Zhang, He Pan, Daian Wu, Xingquan Su, Wenjie Tang, Xiaolei Zhao, Daqing Sun, Liwei Song, Bailin Bai, Xueyuan Li, Xiangyan |
author_facet | Zhang, He Pan, Daian Wu, Xingquan Su, Wenjie Tang, Xiaolei Zhao, Daqing Sun, Liwei Song, Bailin Bai, Xueyuan Li, Xiangyan |
author_sort | Zhang, He |
collection | PubMed |
description | Panax notoginseng (Burk.) F.H. Chen has long been used to stop bleeding for hundreds of years in China. At present, only dencichine, notoginsenoside Ft1, and 20(S)-protopanaxadiol (PPD) showed hemostatic effect. However, the molecular mechanism of PPD on the platelet aggragetion needs to be further investigated. The study aims to evaluate the hemostatic effect of PPD and reveal its interacting targets using a series of experiments. In this study, the bleeding time was measured in mouse tail amputation and liver scratch models to evaluate hemostatic effect of PPD. The routine blood and plasma coagulation parameters in NS, HC, and PPD (2, 4, and 8 mg/kg) groups were measured using a blood analyzer. Platelet aggregation rate and ATP release were analyzed by a platelet aggregometer. Subsequently, the degranulation marker CD62P and PAC-1, and the concentrations of cytosolic Ca(2+) ([Ca(2+)](i)), cAMP, cGMP, and PAC-1 expressions were also assessed. We found that PPD shorted the bleeding time on the mouse tail amputation and liver scratch models and mainly increased blood platelet count in the rats after subcutaneous injection for 4 h. Meanwhile, PPD decreased APTT, increased FIB content, and directly induced platelet aggregation in vitro. In the absence of Ca(2+), PPD induced the increase of [Ca(2+)](i) and slightly increased the levels of CD62P and PAC-1. After the addition of 1 mM Ca(2+), PPD treatment markedly promoted platelet activation by promoting ATP level, releasing CD62P and increasing PAC-1 binding in washed platelets. Excitingly, PPD-induced changes including platelet aggregation, decreased cAMP content, and the increases of CD62P and PAC-1 were significantly reversed by protease-activated receptor 1 (PAR-1) antagonist, vorapaxar, which showed similar function as thrombin. In addition, molecular docking analysis and ELISA assay demonstrated that PPD had a promising docking score with -6.6 kcal/mol and increased PAR-1 expression in human platelets, which indicated that PAR-1 is involved in PPD-induced platelet aggregation by regulating calcium signaling. Collectively, our study could provide the new insights of PPD as an essential hemostatic ingredient in Panax notoginseng for the treatment of hemorrhagic disease. |
format | Online Article Text |
id | pubmed-7530267 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75302672020-10-09 Platelet Protease Activated Receptor 1 Is Involved in the Hemostatic Effect of 20(S)-Protopanaxadiol by Regulating Calcium Signaling Zhang, He Pan, Daian Wu, Xingquan Su, Wenjie Tang, Xiaolei Zhao, Daqing Sun, Liwei Song, Bailin Bai, Xueyuan Li, Xiangyan Front Pharmacol Pharmacology Panax notoginseng (Burk.) F.H. Chen has long been used to stop bleeding for hundreds of years in China. At present, only dencichine, notoginsenoside Ft1, and 20(S)-protopanaxadiol (PPD) showed hemostatic effect. However, the molecular mechanism of PPD on the platelet aggragetion needs to be further investigated. The study aims to evaluate the hemostatic effect of PPD and reveal its interacting targets using a series of experiments. In this study, the bleeding time was measured in mouse tail amputation and liver scratch models to evaluate hemostatic effect of PPD. The routine blood and plasma coagulation parameters in NS, HC, and PPD (2, 4, and 8 mg/kg) groups were measured using a blood analyzer. Platelet aggregation rate and ATP release were analyzed by a platelet aggregometer. Subsequently, the degranulation marker CD62P and PAC-1, and the concentrations of cytosolic Ca(2+) ([Ca(2+)](i)), cAMP, cGMP, and PAC-1 expressions were also assessed. We found that PPD shorted the bleeding time on the mouse tail amputation and liver scratch models and mainly increased blood platelet count in the rats after subcutaneous injection for 4 h. Meanwhile, PPD decreased APTT, increased FIB content, and directly induced platelet aggregation in vitro. In the absence of Ca(2+), PPD induced the increase of [Ca(2+)](i) and slightly increased the levels of CD62P and PAC-1. After the addition of 1 mM Ca(2+), PPD treatment markedly promoted platelet activation by promoting ATP level, releasing CD62P and increasing PAC-1 binding in washed platelets. Excitingly, PPD-induced changes including platelet aggregation, decreased cAMP content, and the increases of CD62P and PAC-1 were significantly reversed by protease-activated receptor 1 (PAR-1) antagonist, vorapaxar, which showed similar function as thrombin. In addition, molecular docking analysis and ELISA assay demonstrated that PPD had a promising docking score with -6.6 kcal/mol and increased PAR-1 expression in human platelets, which indicated that PAR-1 is involved in PPD-induced platelet aggregation by regulating calcium signaling. Collectively, our study could provide the new insights of PPD as an essential hemostatic ingredient in Panax notoginseng for the treatment of hemorrhagic disease. Frontiers Media S.A. 2020-09-18 /pmc/articles/PMC7530267/ /pubmed/33041793 http://dx.doi.org/10.3389/fphar.2020.549150 Text en Copyright © 2020 Zhang, Pan, Wu, Su, Tang, Zhao, Sun, Song, Bai and Li http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Zhang, He Pan, Daian Wu, Xingquan Su, Wenjie Tang, Xiaolei Zhao, Daqing Sun, Liwei Song, Bailin Bai, Xueyuan Li, Xiangyan Platelet Protease Activated Receptor 1 Is Involved in the Hemostatic Effect of 20(S)-Protopanaxadiol by Regulating Calcium Signaling |
title | Platelet Protease Activated Receptor 1 Is Involved in the Hemostatic Effect of 20(S)-Protopanaxadiol by Regulating Calcium Signaling |
title_full | Platelet Protease Activated Receptor 1 Is Involved in the Hemostatic Effect of 20(S)-Protopanaxadiol by Regulating Calcium Signaling |
title_fullStr | Platelet Protease Activated Receptor 1 Is Involved in the Hemostatic Effect of 20(S)-Protopanaxadiol by Regulating Calcium Signaling |
title_full_unstemmed | Platelet Protease Activated Receptor 1 Is Involved in the Hemostatic Effect of 20(S)-Protopanaxadiol by Regulating Calcium Signaling |
title_short | Platelet Protease Activated Receptor 1 Is Involved in the Hemostatic Effect of 20(S)-Protopanaxadiol by Regulating Calcium Signaling |
title_sort | platelet protease activated receptor 1 is involved in the hemostatic effect of 20(s)-protopanaxadiol by regulating calcium signaling |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530267/ https://www.ncbi.nlm.nih.gov/pubmed/33041793 http://dx.doi.org/10.3389/fphar.2020.549150 |
work_keys_str_mv | AT zhanghe plateletproteaseactivatedreceptor1isinvolvedinthehemostaticeffectof20sprotopanaxadiolbyregulatingcalciumsignaling AT pandaian plateletproteaseactivatedreceptor1isinvolvedinthehemostaticeffectof20sprotopanaxadiolbyregulatingcalciumsignaling AT wuxingquan plateletproteaseactivatedreceptor1isinvolvedinthehemostaticeffectof20sprotopanaxadiolbyregulatingcalciumsignaling AT suwenjie plateletproteaseactivatedreceptor1isinvolvedinthehemostaticeffectof20sprotopanaxadiolbyregulatingcalciumsignaling AT tangxiaolei plateletproteaseactivatedreceptor1isinvolvedinthehemostaticeffectof20sprotopanaxadiolbyregulatingcalciumsignaling AT zhaodaqing plateletproteaseactivatedreceptor1isinvolvedinthehemostaticeffectof20sprotopanaxadiolbyregulatingcalciumsignaling AT sunliwei plateletproteaseactivatedreceptor1isinvolvedinthehemostaticeffectof20sprotopanaxadiolbyregulatingcalciumsignaling AT songbailin plateletproteaseactivatedreceptor1isinvolvedinthehemostaticeffectof20sprotopanaxadiolbyregulatingcalciumsignaling AT baixueyuan plateletproteaseactivatedreceptor1isinvolvedinthehemostaticeffectof20sprotopanaxadiolbyregulatingcalciumsignaling AT lixiangyan plateletproteaseactivatedreceptor1isinvolvedinthehemostaticeffectof20sprotopanaxadiolbyregulatingcalciumsignaling |